Gilead Sciences, Inc. (LON:0QYQ)
London · Delayed Price · Currency is GBP · Price in USD 110.89
-1.78 (-1.58%)
At close: Sep 16, 2025
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of 100.79 billion as of September 17, 2025. Its market cap has increased by 34.11% in one year.
Market Cap
100.79B
Enterprise Value
113.17B
Revenue
21.07B
Ranking
n/a
PE Ratio
21.88
Stock Price
110.89
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 138.73M to 100.79B, an increase of 72,555.40%. That is a compound annual growth rate of 21.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 100.79B | 9.62% |
| Dec 31, 2024 | 91.95B | 16.03% |
| Dec 29, 2023 | 79.25B | -11.32% |
| Dec 30, 2022 | 89.37B | 32.86% |
| Dec 31, 2021 | 67.26B | 25.75% |
| Dec 31, 2020 | 53.49B | -13.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 176.72B |
| HSBC Holdings | 172.54B |
| Shell | 151.87B |
| Unilever | 113.08B |
| Rolls-Royce Holdings | 94.93B |
| British American Tobacco p.l.c. | 89.39B |
| Rio Tinto Group | 78.88B |
| BP p.l.c. | 65.15B |